Format

Send to

Choose Destination
Am J Med. 2002 Oct 1;113(5):419-23.

Myocarditis in systemic lupus erythematosus.

Author information

1
Department of Medicine, University of Hawaii, Honolulu, Hawaii, USA.

Abstract

Although clinical manifestations of myocarditis in systemic lupus erythematosus are uncommon, noninvasive cardiac testing may detect subclinical cases. The pathogenesis of myocarditis in systemic lupus erythematosus has been ascribed to many factors, including autoimmunity, medications, and coexisting diseases. Lupus myocarditis merits urgent clinical attention because of the likely progression to arrhythmias, conduction disturbances and heart block, dilated cardiomyopathy, and heart failure. Endomyocardial biopsy can be used to identify the underlying inflammatory histopathology. Usual therapy includes high-dose corticosteroids, in addition to standard cardiac medications.

PMID:
12401537
DOI:
10.1016/s0002-9343(02)01223-8
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center